Which medications in the drug class Combination Products are used in the treatment of Benign Prostatic Hyperplasia (BPH)?

Updated: Feb 19, 2021
  • Author: Levi A Deters, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print

Combination Products

Various combination products are emerging on the market to improve patient compliance and symptoms.

Dutasteride and tamsulosin (Jalyn)

The combination of dutasteride, a 5-alpha-reductase inhibitor, and tamsulosin, an alpha-adrenergic antagonist is indicated for benign prostatic hypertrophy in men with an enlarged prostate. Each cap contains dutasteride 0.5 mg and tamsulosin 0.4 mg.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!